219 related articles for article (PubMed ID: 11120780)
1. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6.
Reljic R; Wagner SD; Peakman LJ; Fearon DT
J Exp Med; 2000 Dec; 192(12):1841-8. PubMed ID: 11120780
[TBL] [Abstract][Full Text] [Related]
2. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene.
Vasanwala FH; Kusam S; Toney LM; Dent AL
J Immunol; 2002 Aug; 169(4):1922-9. PubMed ID: 12165517
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanisms that determine the development and function of plasma cells.
Calame KL; Lin KI; Tunyaplin C
Annu Rev Immunol; 2003; 21():205-30. PubMed ID: 12524387
[TBL] [Abstract][Full Text] [Related]
4. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.
Diehl SA; Schmidlin H; Nagasawa M; van Haren SD; Kwakkenbos MJ; Yasuda E; Beaumont T; Scheeren FA; Spits H
J Immunol; 2008 Apr; 180(7):4805-15. PubMed ID: 18354204
[TBL] [Abstract][Full Text] [Related]
5. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.
Fujita N; Jaye DL; Geigerman C; Akyildiz A; Mooney MR; Boss JM; Wade PA
Cell; 2004 Oct; 119(1):75-86. PubMed ID: 15454082
[TBL] [Abstract][Full Text] [Related]
6. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation.
Tunyaplin C; Shaffer AL; Angelin-Duclos CD; Yu X; Staudt LM; Calame KL
J Immunol; 2004 Jul; 173(2):1158-65. PubMed ID: 15240705
[TBL] [Abstract][Full Text] [Related]
7. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
[TBL] [Abstract][Full Text] [Related]
8. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6.
Ozaki K; Spolski R; Ettinger R; Kim HP; Wang G; Qi CF; Hwu P; Shaffer DJ; Akilesh S; Roopenian DC; Morse HC; Lipsky PE; Leonard WJ
J Immunol; 2004 Nov; 173(9):5361-71. PubMed ID: 15494482
[TBL] [Abstract][Full Text] [Related]
9. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.
Crotty S; Johnston RJ; Schoenberger SP
Nat Immunol; 2010 Feb; 11(2):114-20. PubMed ID: 20084069
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific modulation of IFN-regulatory factor 4 function by Krüppel-type zinc finger proteins.
Gupta S; Anthony A; Pernis AB
J Immunol; 2001 May; 166(10):6104-11. PubMed ID: 11342629
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.
Ochiai K; Maienschein-Cline M; Simonetti G; Chen J; Rosenthal R; Brink R; Chong AS; Klein U; Dinner AR; Singh H; Sciammas R
Immunity; 2013 May; 38(5):918-29. PubMed ID: 23684984
[TBL] [Abstract][Full Text] [Related]
12. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
13. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Bhattacharya S; Conolly RB; Kaminski NE; Thomas RS; Andersen ME; Zhang Q
Toxicol Sci; 2010 May; 115(1):51-65. PubMed ID: 20123757
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
15. The proto-oncogene BCL-6 in normal and malignant B cell development.
Niu H
Hematol Oncol; 2002 Dec; 20(4):155-66. PubMed ID: 12469325
[TBL] [Abstract][Full Text] [Related]
16. BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production.
Yu RY; Wang X; Pixley FJ; Yu JJ; Dent AL; Broxmeyer HE; Stanley ER; Ye BH
Blood; 2005 Feb; 105(4):1777-84. PubMed ID: 15507530
[TBL] [Abstract][Full Text] [Related]
17. Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6.
Staudt LM; Dent AL; Shaffer AL; Yu X
Int Rev Immunol; 1999; 18(4):381-403. PubMed ID: 10626250
[TBL] [Abstract][Full Text] [Related]
18. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.
Shaffer AL; Yu X; He Y; Boldrick J; Chan EP; Staudt LM
Immunity; 2000 Aug; 13(2):199-212. PubMed ID: 10981963
[TBL] [Abstract][Full Text] [Related]
19. Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells.
Nagy M; Chapuis B; Matthes T
Br J Haematol; 2002 Feb; 116(2):429-35. PubMed ID: 11841448
[TBL] [Abstract][Full Text] [Related]
20. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
